当前位置:首页 - 行情中心 - 东诚药业(002675) - 财务分析 - 现金流量表

东诚药业

(002675)

  

流通市值:110.62亿  总市值:122.70亿
流通股本:7.43亿   总股本:8.25亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,095,780,834.071,425,303,428.45676,274,968.582,841,498,819.56
  收到的税费返还58,599,504.8939,053,045.5420,576,102.6294,095,466.3
  收到其他与经营活动有关的现金48,611,095.5528,175,199.678,815,779.8895,272,846.93
  经营活动现金流入小计2,202,991,434.511,492,531,673.66705,666,851.083,030,867,132.79
  购买商品、接受劳务支付的现金803,640,810.39520,393,984.23218,320,022.361,393,435,814.56
  支付给职工以及为职工支付的现金410,403,134.24286,060,350.49168,579,902.52486,620,513.34
  支付的各项税费202,197,140.59146,662,515.7463,175,805.32241,080,519.7
  支付其他与经营活动有关的现金445,756,021.72271,808,548.15141,554,630.58622,579,505.66
  经营活动现金流出小计1,861,997,106.941,224,925,398.61591,630,360.782,743,716,353.26
  经营活动产生的现金流量净额340,994,327.57267,606,275.05114,036,490.3287,150,779.53
二、投资活动产生的现金流量:
  收回投资收到的现金884,840,000522,000,000244,000,000822,673,958
  取得投资收益收到的现金4,076,770.732,938,148.73948,193.066,233,098.33
  处置固定资产、无形资产和其他长期资产收回的现金净额8,761,687.064,152,581.3429,604.78716,682.04
  收到的其他与投资活动有关的现金220,000--1,646,000
  投资活动现金流入小计897,898,457.79529,090,730.07244,977,797.84831,269,738.37
  购建固定资产、无形资产和其他长期资产支付的现金202,127,232.34162,407,869.3973,831,730.92456,093,958.61
  投资支付的现金1,046,437,917.94669,485,479.45248,328,0001,086,717,900.78
  取得子公司及其他营业单位支付的现金---3,456,315.31
  支付其他与投资活动有关的现金255,115.49115.49--
  投资活动现金流出小计1,248,820,265.77831,893,464.33322,159,730.921,546,268,174.7
  投资活动产生的现金流量净额-350,921,807.98-302,802,734.26-77,181,933.08-714,998,436.33
三、筹资活动产生的现金流量:
  吸收投资收到的现金426,160,000230,160,000115,160,000689,600,000
  取得借款收到的现金464,343,346375,969,993.4187,734,352.41878,181,835.2
  收到其他与筹资活动有关的现金24,054,220.6126,829,220.61-8,912,727.86
  筹资活动现金流入小计914,557,566.61632,959,214.02202,894,352.411,576,694,563.06
  偿还债务支付的现金578,270,532.14540,939,397.81274,122,584.14790,913,049.72
  分配股利、利润或偿付利息支付的现金90,095,905.2174,498,623.6721,571,826.73217,253,332.68
  支付其他与筹资活动有关的现金17,306,698.0213,724,400.2312,546,349.0524,947,035.08
  筹资活动现金流出小计685,673,135.37629,162,421.71308,240,759.921,033,113,417.48
  筹资活动产生的现金流量净额228,884,431.243,796,792.31-105,346,407.51543,581,145.58
四、汇率变动对现金及现金等价物的影响2,482,833.66,625,400.823,590,080.2712,148,894.68
五、现金及现金等价物净增加额221,439,784.43-24,774,266.08-64,901,770.02127,882,383.46
  加:期初现金及现金等价物余额735,620,565.08735,620,565.08735,620,565.08607,738,181.62
  期末现金及现金等价物余额957,060,349.51710,846,299670,718,795.06735,620,565.08
补充资料:
  净利润-70,039,313.7-141,425,009.68
  资产减值准备-7,556,002.72-101,336,585.19
  固定资产和投资性房地产折旧-80,090,433.86-136,486,970.98
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-80,090,433.86-136,486,970.98
  无形资产摊销-8,468,534-17,852,134.53
  长期待摊费用摊销-8,759,079-9,525,298.99
  处置固定资产、无形资产和其他长期资产的损失--194,231.24--302,727.5
  固定资产报废损失-71,479.95-93,484.23
  公允价值变动损失-610,065.75--1,068,427.73
  财务费用-56,134,167.63-80,325,376.9
  投资损失-6,374,584.07-13,984,963.44
  递延所得税--14,271,863.04--7,520,816.93
  其中:递延所得税资产减少--13,696,532.37--6,715,351.04
    递延所得税负债增加--575,330.67--805,465.89
  存货的减少-16,832,512.54-261,389,737.05
  经营性应收项目的减少--45,882,705.2--124,861,810.36
  经营性应付项目的增加-51,269,852.49--447,963,732.93
  其他-11,829,034.35-95,835,413.12
  现金的期末余额-710,846,299-735,620,565.08
  减:现金的期初余额-735,620,565.08-607,738,181.62
  现金及现金等价物的净增加额--24,774,266.08-127,882,383.46
公告日期2025-10-292025-08-152025-04-302025-02-27
审计意见(境内)标准无保留意见
TOP↑